Condition: Cataract · Endothelial Cell Loss, Corneal · Sponsor: Asociación para Evitar la Ceguera en México
The goal of this clinical study is to assess the safety of intracameral injection of EO2002 in subjects post-cataract surgery.
This description comes directly from the study's public registry record.
Yara Luna · 55 39 53 12 25 · reclutamiento.proyectos@apec.com.mx
Always discuss trial participation with your own doctor first.
| Asociacion para Evitar la Ceguera en Mexico | Mexico City, Mexico City, Mexico | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05587205